AKBA
Akebia Therapeutics Inc.
-38.05%
$1.13 - $0.70
Feb 7th 2023 - Mar 21st 2023
positive
negative
Oct, 17, 2022
Vadadustat had the best safety profile of any HIF ... See more
Oct, 10, 2022
$AKBA just as Rls787 said vad looks like it passed... See more
positive
negative
Jan, 15, 2023
If we pass 1$ I will think to buy more
Oct, 13, 2022
$SDC fuck it too good to pass on .
positive
negative
Oct, 17, 2022
Vadadustat had the best safety profile of any HIF and passed both the DD and NDD trails in the US,
Oct, 10, 2022
$AKBA just as Rls787 said vad looks like it passed EMA PRAC so the drug seems safe and good risk to use advantage